He just mentioned that with the amount of data that is being gathered, it is not just a pass or fail trial, and the analysis of it needs to be thorough. That covid-19 did have an impact on some of the trial locations was mentioned, however he felt confident that the results of it would be "very good" and that was encouraging to me. As far as pursuing a PA upon the results being revealed, I think that the talk here lately of BIIB or others trying to step in may be one of the reasons, so that they can increase market cap to thwart off any hostile activities, imho. I do have issue with Dr. Misslings presentation skills, however that doesn't diminish the science.
Market Data 
Markets 
AI
